Maplelane Capital’s DocuSign DOCU Stock Holding History

Maplelane Capital’s Portfolio DOCU Stock Details DOCU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-210,000	Closed	-$15.6M	–	99
2019 Q4	$15.6M	Sell	210,000 -885,000	-81%	-$60.8M	0.42%	65
2019 Q3	$67.8M	Buy	+1,095,000	New	+$57.3M	1.52%	15
2018 Q4	–	Sell	-175,000	Closed	-$9.2M	–	122
2018 Q3	$9.2M	Buy	+175,000	New	+$9.93M	0.31%	72

Other funds holding DOCU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

NMO

Newlands Management Operations Dallas, Texas $15.5B AUM 25.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Maplelane Capital's DOCU Position: Q2 2024 in Review

Maplelane Capital sold out of DocuSign (DOCU) in Q2 2024, closing a stake of 555,000 shares — an estimated $33.1M sold.

Maplelane Capital first reported a position in DOCU in Q4 2019 and held it in 4 quarters. The position peaked at $33.1M in Q1 2024. 664 funds tracked by Wall St. Rank hold DOCU as of Q2 2024.

Maplelane Capital reported no remaining DocuSign position as of Q2 2024 after selling out during the quarter.
Maplelane Capital sold 555,000 DocuSign shares in Q2 2024, an estimated $33.1M.
Maplelane Capital first reported a position in DocuSign in Q4 2019 and held it in 4 quarters.
Maplelane Capital's DocuSign position peaked at $33.1M in Q1 2024.
664 funds tracked by Wall St. Rank held DocuSign as of Q2 2024.

Based on Maplelane Capital's 13F filing for Q2 2024, filed 14 Aug 2024.